Literature DB >> 8528552

[3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.

A C MacKinnon1, W S Redfern, C M Brown.   

Abstract

1. RS-45041-190 (4-chloro-2-(imidazolin-2-yl)isoindoline) is an I2 imidazoline receptor ligand with the highest affinity and selectivity so far described; [3H]-RS-45041-190 has a tritium atom attached to the 7-position on the isoindoline ring. 2. [3H]-RS-45041-190 binding to rat kidney membranes was saturable (Bmax = 223.1 +/- 18.4 fmol mg-1 protein) and of high affinity (Kd = 2.71 +/- 0.59 nM). Kinetic studies revealed that the binding was rapid and reversible, with [3H]-RS-45041-190 interacting with two sites or two affinity states. 3. Competition studies showed that 60-70% of [3H]-RS-45041-190 binding (1 nM) was specifically to imidazoline binding sites of the I2 subtype, characterized by high affinity for idazoxan (pIC50 7.85 +/- 0.03) and cirazoline (pIC50 8.16 +/- 0.05). The remaining 30-40% was displaced specifically by the monoamine oxidase A inhibitors, clorgyline and pargyline. 4. alpha 1- and alpha 2-adrenoceptor, I1 imidazoline, histamine, 5-hydroxytryptamine or dopamine receptor ligands had low affinity suggesting that [3H]-RS-45041-190 did not label receptors of these classes. 5. In autoradiography studies, [3H]-RS-45041-190 labelled discrete regions of rat brain corresponding to the distribution of I2 subtypes, notably the subfornical organ, arcuate nucleus, interpeduncular nucleus, medial habenular nucleus and lateral mammillary nucleus, and additional sites in the locus coeruleus, dorsal raphe and dorsomedial hypothalamic nucleus. 6. [3H]-RS-45041-190 therefore labels I2 receptors with high affinity, and an additional site which has high affinity for some monoamine oxidase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528552      PMCID: PMC1909102          DOI: 10.1111/j.1476-5381.1995.tb16655.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

2.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

3.  Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla.

Authors:  P Ernsberger; M P Meeley; J J Mann; D J Reis
Journal:  Eur J Pharmacol       Date:  1987-01-28       Impact factor: 4.432

4.  Amiloride interacts with [3H]idazoxan and [3H]rauwolscine binding sites in rabbit urethra.

Authors:  F Yablonsky; J P Dausse
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

5.  Distribution of immunoreactive Met-enkephalin-Arg6-Gly7-Leu8 and Leu-enkephalin in discrete regions of the rat brain.

Authors:  N Zamir; M Palkovits; M Brownstein
Journal:  Brain Res       Date:  1985-02-04       Impact factor: 3.252

6.  [3H]yohimbine and [3H]idazoxan bind to different sites on rabbit forebrain and kidney membranes.

Authors:  C A Hamilton; J L Reid; M A Yakubu
Journal:  Eur J Pharmacol       Date:  1988-02-09       Impact factor: 4.432

7.  The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem.

Authors:  G Bricca; M Dontenwill; A Molines; J Feldman; A Belcourt; P Bousquet
Journal:  Eur J Pharmacol       Date:  1989-03-14       Impact factor: 4.432

Review 8.  Anatomy and physiology of the neuroendocrine arcuate nucleus.

Authors:  B M Chronwall
Journal:  Peptides       Date:  1985       Impact factor: 3.750

9.  RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

Authors:  C M Brown; A C MacKinnon; W S Redfern; A Williams; C Linton; M Stewart; R U Clague; R Clark; M Spedding
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin.

Authors:  V Glover; J M Halket; P J Watkins; A Clow; B L Goodwin; M Sandler
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

View more
  6 in total

1.  Neuroanatomical characterization of imidazoline I2 receptor agonist-induced antinociception.

Authors:  Justin N Siemian; Shushan Jia; Jian-Feng Liu; Yanan Zhang; Jun-Xu Li
Journal:  Eur J Neurosci       Date:  2018-03-23       Impact factor: 3.386

2.  No evidence for functional imidazoline receptors on locus coeruleus neurons.

Authors:  B Szabo; R Fröhlich; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

3.  Comparison of post-junctional alpha-adrenoceptors in iris dilator muscle of humans, and albino and pigmented rabbits.

Authors:  H Ishikawa; D D Miller; P N Patil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

4.  RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

Authors:  C M Brown; A C MacKinnon; W S Redfern; A Williams; C Linton; M Stewart; R U Clague; R Clark; M Spedding
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Mechanisms of imidazoline I2 receptor agonist-induced antinociception in rats: involvement of monoaminergic neurotransmission.

Authors:  Justin N Siemian; Kaixuan Wang; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

6.  Agmatine modulates spontaneous activity in neurons of the rat medial habenular complex-a relevant mechanism in the pathophysiology and treatment of depression?

Authors:  Torsten Weiss; René Bernard; Hans-Gert Bernstein; Rüdiger W Veh; Gregor Laube
Journal:  Transl Psychiatry       Date:  2018-09-24       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.